Turkey’s Talent Hope
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Address: Ekinciler cad. No: 1, Floor: 2, 34 810 Kavacık Beykoz Istanbul,Turkey
Tel: 0216 680 29 29
Web: http://www.egisturkey.com/
Egis which is one of the leading pharmaceutical companies in Central Europe in 1913, began working on behalf of human health, same as in Turkey, the evidence of ethical approach to work with.
Separating R & D activities accounted for 8% of revenue, with 1618 licensed product Egis, producing a high purity and efficiency, the active ingredient that has been awarded a multi-molecule.
Egis has a fairly large market share in Eastern European countries, America and Japan, also provide the active ingredient. Production of high quality products with the active ingredient in its own structure contains patented.
Egis is the primary priority of human health, working with the principle of ethical approach, creative and expert team has started its operations in Turkey since April 2006.
Cardiovascular system in the world, Central Nervous System , which provides service to the respiratory and digestive system medicines Egis, Hungary, Turkey, and is located in the Central Nervous System won innovation awards medicines registered high production standard, produced, pioneering and innovative medicines in this field to create differences
continue is.
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Ersin Erfa, general manager of Centurion, which recently set up one of Turkey’s largest biotechnology plants in Ankara, dives into the world of double-digit growth and a booming export business,…
Prof. Dr. Sabahattin Aydın, Rector of Medipol University, chairman of the Executive Council of TUSAP Healthcare Platform, former executive board member of the World Health Organization (WHO), former deputy undersecretary…
Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare…
Hasan Ulusoy, chairman of Nobel Ilac, elaborates on his company’s tremendous successes in Turkey and how they have differentiated themselves through early investment in biotechnology and firmly grasping international opportunities.…
Hakan Yurdakul, Head of Economy Monitoring and Coordination at the Presidency Office of the Republic of Turkey, elaborates on the strategic importance of the pharmaceutical and healthcare industries for the…
Prof. Dr. Temel Yilmaz, president of the Turkish Diabetes Foundation, discussed how the disease has made a massive impact in country and what can be done to tackle the issue…
Two months into the role, Umut Meriç, general manager for Chiesi Turkey, discusses the affiliate’s rapid progression and his plans to ensure Turkish patients benefit from the global company’s latest…
From collaborating with authorities to tackling awareness surrounding mental illnesses, Altan Gorseval, country manager of Lundbeck Turkey, paints an accurate picture of the company’s dedication to improving mental health and…
Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one…
Dr. Hakkı Gürsöz, president of the Turkish Medicines and Medical Devices Agency (TiTCK), provides insights into recent localization and pricing policies and delivers strong messages to both domestic and foreign…
Dr. Erdal Bozdoğan, the recently appointed general manager of Takeda Turkey, leverages his 20 years of experience in the pharmaceutical industry and his expertise of emerging markets to document Turkey’s…
See our Cookie Privacy Policy Here
